Beijing Aosaikang Pharmaceutical News

Osecon (002755) First Coverage Report: Gathering shortages are gradually bottoming out, and innovation and transformation are about to usher in gains

國元證券Jun 1 11:00

Osecon (002755): Waiting for breakthroughs in innovation-driven transformation

東方證券Mar 11 06:02

Osecon (002755): The impact of generic drug collection has bottomed out, and the innovative drug pipeline will enter the harvest period

財通證券Dec 15, 2023 10:00

Osecon (002755): The acquisition of Weidecang Incident Landing Pharmaceutical Devices Collaborates to Enhance Competitiveness in the Digestive Field

國海證券May 5, 2021 11:00

Osecon (002755) incident review: Maltol iron capsules with excellent Q1 performance were successfully approved and clinical marketing is expected quickly

國海證券Mar 28, 2021 11:00

Osecon (002755): A series of surprises after collaborating with Pharmaceutical Mingkang New Drug to land an innovative drug pipeline

國海證券Mar 20, 2021 11:00

Osecon (002755) Incident Review: 2020 Performance Slightly Exceeds Expectations Subsidiary Patent Authorization Model Highlights Value of Innovative Platforms

國海證券Feb 20, 2021 10:00

Comment on the Osaikang (002755) event: the second domestic anti-tumor drug temozolomide for injection was approved by PPI leader to expand its multi-product line for accelerated growth.

國海證券Jan 20, 2021 10:00

Osecon (002755) In-depth Report: PPI's Leading Multi-Product Line Expansion Enters Accelerated Growth, New First-tier Pharmaceutical Group Innovation Force Rises

國海證券Oct 27, 2020 11:00

Osaikang (002755): significant recovery of results in the third quarter, R & D and steady progress in the future

天風證券Oct 25, 2020 11:00

Osaikang (002755): affected by the epidemic in the first half of the year, the performance declined compared with the same period last year, Q2 improved and was optimistic about the company's long-term development.

天風證券Aug 25, 2020 11:00

Osaikang (002755): high-end first imitation + innovative drugs blossom on domestic PPI leading stars shine

天風證券May 9, 2020 11:00

Oriental New Star (002755): the performance inflection point has come to actively seek business transformation.

天風證券Apr 20, 2017 11:00

东方新星(002755)调研简报：行业低谷 未来可期

東興證券Jul 26, 2016 11:00

Oriental New Star (002755) In-depth Report: The main business has excellent technical strength, and exploration of related fields is worth looking forward to

廣發證券Apr 16, 2016 11:00

Oriental New Star (002755) In-depth Research: The main business has excellent technical strength, and exploration of related fields is worth looking forward to

廣發證券Apr 12, 2016 11:00

[Guangfa Securities] Oriental Xinxing In-depth Report: The main business has excellent technical strength, and related field exploration is worth looking forward to

廣發證券Apr 12, 2016 11:00

Oriental Rising Star (002755) Annual Report Review: Controlled Industries Await Strength Amid Slump and Dormant

長江證券Mar 31, 2016 11:00

[Northeast Securities] Dongfang Xinxing: A leading domestic survey and geotechnical engineering enterprise

東北證券May 13, 2015 11:00

[Hengtai Securities] Oriental Rising Star: The initial stock price pressure level of the company's initial listing is expected to be 21 yuan to 25 yuan

恆泰證券May 5, 2015 11:00